JPH0375529B2 - - Google Patents

Info

Publication number
JPH0375529B2
JPH0375529B2 JP57056690A JP5669082A JPH0375529B2 JP H0375529 B2 JPH0375529 B2 JP H0375529B2 JP 57056690 A JP57056690 A JP 57056690A JP 5669082 A JP5669082 A JP 5669082A JP H0375529 B2 JPH0375529 B2 JP H0375529B2
Authority
JP
Japan
Prior art keywords
tnf
solution
albumin
activity
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57056690A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58174330A (ja
Inventor
Hajime Sakamoto
Takao Kyota
Hiroshi Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Kogyo KK filed Critical Asahi Kasei Kogyo KK
Priority to JP57056690A priority Critical patent/JPS58174330A/ja
Priority to HU83981A priority patent/HU189251B/hu
Priority to US06/477,866 priority patent/US4447355A/en
Priority to EP83301740A priority patent/EP0091258B2/en
Priority to AT83301740T priority patent/ATE29666T1/de
Priority to DE8383301740T priority patent/DE3373628D1/de
Priority to CA000424749A priority patent/CA1187412A/en
Priority to IT67372/83A priority patent/IT1162845B/it
Priority to FR8305540A priority patent/FR2530472B1/fr
Priority to BE0/210494A priority patent/BE896383A/fr
Priority to KR1019830001415A priority patent/KR860000842B1/ko
Priority to ES521266A priority patent/ES8505546A1/es
Priority to CH1885/83A priority patent/CH656534A5/fr
Publication of JPS58174330A publication Critical patent/JPS58174330A/ja
Publication of JPH0375529B2 publication Critical patent/JPH0375529B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP57056690A 1982-04-07 1982-04-07 ガン壊死因子の安定化法 Granted JPS58174330A (ja)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP57056690A JPS58174330A (ja) 1982-04-07 1982-04-07 ガン壊死因子の安定化法
HU83981A HU189251B (en) 1982-04-07 1983-03-23 Process for stabilizing tumor necrosis factor
US06/477,866 US4447355A (en) 1982-04-07 1983-03-23 Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same
EP83301740A EP0091258B2 (en) 1982-04-07 1983-03-28 Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor
AT83301740T ATE29666T1 (de) 1982-04-07 1983-03-28 Verfahren zur stabilisierung eines die nekrose von tumoren induzierenden faktors und stabile waesserige loesung oder pulver mit diesem faktor.
DE8383301740T DE3373628D1 (en) 1982-04-07 1983-03-28 Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor
CA000424749A CA1187412A (en) 1982-04-07 1983-03-29 Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same
IT67372/83A IT1162845B (it) 1982-04-07 1983-04-05 Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione acquosa stabile o polvere che lo contiene
FR8305540A FR2530472B1 (fr) 1982-04-07 1983-04-05 Procede pour stabiliser un facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur
BE0/210494A BE896383A (fr) 1982-04-07 1983-04-06 Procede pour stabiliser un facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur
KR1019830001415A KR860000842B1 (ko) 1982-04-07 1983-04-06 종양 괴사 인자의 안정화 방법
ES521266A ES8505546A1 (es) 1982-04-07 1983-04-06 Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores.
CH1885/83A CH656534A5 (fr) 1982-04-07 1983-04-07 Procede pour stabiliser un facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57056690A JPS58174330A (ja) 1982-04-07 1982-04-07 ガン壊死因子の安定化法

Publications (2)

Publication Number Publication Date
JPS58174330A JPS58174330A (ja) 1983-10-13
JPH0375529B2 true JPH0375529B2 (enrdf_load_stackoverflow) 1991-12-02

Family

ID=13034438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57056690A Granted JPS58174330A (ja) 1982-04-07 1982-04-07 ガン壊死因子の安定化法

Country Status (2)

Country Link
JP (1) JPS58174330A (enrdf_load_stackoverflow)
BE (1) BE896383A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126217A (ja) * 1983-12-14 1985-07-05 Sumitomo Chem Co Ltd 長期徐放性製剤
JP2629000B2 (ja) * 1986-07-18 1997-07-09 中外製薬株式会社 安定な顆粒球コロニー刺激因子含有製剤
WO1989006532A1 (en) * 1988-01-13 1989-07-27 Dainippon Pharmaceutical Co., Ltd. Oozing-proof liposome preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108821A (en) * 1979-02-14 1980-08-21 Kanebo Ltd Preparation of antitumor agent
JPS5716823A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Live mumps vaccine pharmaceutical and stabilizing method

Also Published As

Publication number Publication date
BE896383A (fr) 1983-08-01
JPS58174330A (ja) 1983-10-13

Similar Documents

Publication Publication Date Title
US4447355A (en) Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same
CN1149283C (zh) 稳定谷氨酰胺转移酶制剂及其生产方法
CA1329543C (en) Human growth hormone formulation
US7244426B2 (en) Pharmaceutical compositions of fibrinolytic agent
JP2000510813A (ja) Ｉｌ−１２用処方
EP2258402A2 (en) Dried composition
JPH03505334A (ja) 凍結乾燥されたペプチド製剤
US5714458A (en) Stable pharmaceutical compositions containing a fibroblast growth factor
JPH0375529B2 (enrdf_load_stackoverflow)
JPH0314291B2 (enrdf_load_stackoverflow)
JPH0375530B2 (enrdf_load_stackoverflow)
JPH0222233A (ja) スーパーオキシドディスムターゼ組成物
JPH05508640A (ja) 線維芽細胞成長因子を含む安定な医薬組成物
JP2024028905A (ja) ペグアスパラガーゼの凍結乾燥組成物
JPH04198195A (ja) Ｃｐｂ―ｉの安定化方法及び製剤組成物
JPH0375531B2 (enrdf_load_stackoverflow)
JP2825739B2 (ja) 急性肝不全治療剤
Nordstoga et al. Porcine Salmonellosis: II. Production of the Generalized Shwartzman Reaction by Intravenous Injections of Disintegrated Cells of Salmonella Cholerae-Suis
JP2916948B2 (ja) Ｃｐｂ―ｉの安定化方法及びこの製剤組成物
JPS6219531A (ja) 安定なヒト型アンギオテンシン製剤
AU2006200638A1 (en) Pharmaceutical compositions of fibrinolytic agent